In Brief
The endogenous antigens recognized by thymus-derived Treg cells have remained largely undefined. Leonard et al. identify natural Treg cell ligands in mice, demonstrating that two recurrent Treg cell clones recognize distinct nonoverlapping peptides derived from a single prostate-specific protein.
INTRODUCTION
The immune system generates a diverse repertoire of conventional CD4 + T cell clones capable of responding to foreign antigens while restricting immune responses directed at self-antigens. Each CD4 + T cell expresses a unique T cell receptor (TCR) capable of recognizing major histocompatibility complex class II (MHC-II) molecules complexed with short peptides, which are generated from intact proteins by antigen processing. In the process of negative selection, many CD4 + T cells exhibiting strong reactivity to self-peptide-MHC-II (pMHC-II) are eliminated from the conventional T (Tconv) cell repertoire by clonal deletion or differentiation into innate-like T cell lineages (Klein et al., 2014) . In contrast, some CD4 + thymocytes exhibiting overt reactivity to self-pMHC-II ligands differentiate into regulatory T (Treg) cells expressing the transcription factor Foxp3 (Hsieh et al., 2012) ; these function in the periphery to maintain immune homeostasis and suppress autoreactive Tconv cells that evade negative selection. Thus, reactivity to self-antigen is crucial for the establishment of two major tolerance mechanisms: negative selection and Treg cell development, which function in concert to restrict immune responses to self-tissues. Beyond the role of self-pMHC-II recognition in directing Treg cell development in the thymus, the continued recognition of self-antigen outside the thymus is critical for orchestrating Treg cell differentiation, homeostasis, and suppressor activity. Given that self-pMHC-II recognition is central to many facets of Treg cell biology, it is essential to identify the endogenous peptides that trigger Treg cell development in the thymus and are engaged by Treg cells to coordinate immune suppression in the periphery. However, because of technical challenges associated with identifying MHC-II-restricted selfpeptides, the natural antigens recognized by thymus-derived Treg (tTreg) cells have remained undefined. Without this knowledge, it has not been possible to gain a complete understanding of why Treg-cell-mediated suppression is subverted in autoimmune and inflammatory diseases and how Treg cells are coopted by developing cancers to suppress anti-tumor immunity. The paradigm that self-pMHC-II recognition via the TCR drives both the thymic development and the peripheral function of Treg cells is supported by a large body of evidence. Early mouse studies utilizing TCR repertoire profiling revealed that the TCRs expressed by peripheral Treg cells are largely distinct from those expressed by Tconv cells (Hsieh et al., 2004; Hsieh et al., 2006; Lathrop et al., 2008; Wong et al., 2007) , demonstrating that the formation of the Treg cell repertoire is an antigen-driven, TCRdependent process. Consistent with this, developmental studies show that Treg-cell-derived TCRs facilitate thymic differentiation into the Treg cell lineage, whereas Tconv-expressed TCRs are inefficient at directing this process (Bautista et al., 2009; Leung et al., 2009) . Similarly, transgenic expression of a model antigen containing a pMHC-II-binding peptide in the thymus promotes the development or survival of antigen-specific Treg cells (Hsieh et al., 2012) , indicating that TCR-dependent agonist signals promote thymic Treg (tTreg) cell development. More recent studies have demonstrated that the thymic development of some Treg cell specificities is dependent on the expression of autoimmune regulator (Aire) (Malchow et 2 hr after transfer, recipients were immunized with 5 mg Tcaf3 or control protein (Tgm4) or PBS alone. CD4 + T cells from the spleen (left) and pooled skin-draining lymph nodes (right) were analyzed for CTV dilution on day 5. transcription factor that drives the promiscuous expression of tissue-specific antigens in the thymus (Anderson et al., 2002; Derbinski et al., 2005) . In the periphery, a substantial proportion of Treg cells proliferate (Fisson et al., 2003; Smigiel et al., 2014) or perceive strong TCR signals (Moran et al., 2011) at steady state, suggesting that many peripheral Treg cells actively recognize agonist pMHC-II ligands in the absence of inflammation. Likewise, T cells transduced with Treg-cell-derived TCRs can proliferate after transfer into lymphopenic mice, suggesting that some Treg cell TCRs confer reactivity to self-pMHC-II complexes (Hsieh et al., 2004) . Finally, recent work demonstrates that conditional ablation of the TCR on Foxp3 + cells results in systemic autoimmunity (Levine et al., 2014; Vahl et al., 2014) , revealing an important role for TCR-dependent signals in Treg cell differentiation and function in the periphery. The gap in knowledge regarding the identity of endogenous antigens recognized by Treg cells has restricted progress in several fundamental areas of Treg cell biology. First, it has not been possible to analyze the phenotype, frequency, anatomical distribution, and repertoire complexity of Treg cells reactive to natural self-antigens that direct Treg cell differentiation in the thymus. Second, it is unknown whether tTreg TCRs recognize endogenous ligands with unique biochemical or structural characteristics-such as binding affinity, docking mode, or conformational changes-that might provide insight into the mechanisms of Treg-cell-mediated suppression. Third, given the vast array of potential self-peptides in the body, it is unclear whether the protection of tissues from autoimmune attack is dependent on the presence of Treg cells reactive to particular self-pMHC-II complexes. Fourth, it has been challenging to clearly elucidate why some self-reactive T cells are purged by clonal deletion, whereas others are directed into the Treg cell lineage, and whether the affinity of TCR-pMHC-II binding is a primary determinant of these alternate cell fates.
Here, we report the identification of the peptide antigens recognized by two recurrent prostate-specific Treg cell clones, one prevalent in mouse prostate tumors and the other associated with autoimmune lesions of the prostate. These endogenous Treg cell clones recognize distinct non-overlapping MHC-II-restricted peptides from a prostate-specific protein that is frequently targeted by autoantibodies in multiple mouse models of autoimmunity. The link between the antigen specificity of Treg cells and that of autoantibodies that emerge in settings of immune dysregulation has implications for our understanding of Treg-cell-mediated tolerance and reveals a potential strategy for identifying additional Treg cell antigens in mice and humans.
RESULTS
Identification of a Self-pMHC-II Antigen Recognized by MJ23 Treg Cells To reveal the nature of self-peptides recognized by tTreg cells, we aimed to identify a pMHC-II ligand recognized by a naturally occurring Treg cell clone named ''MJ23,'' which we identified previously on the basis of its predominance in mouse prostate tumor lesions (Malchow et al., 2013) . The MJ23 TCR confers reactivity to a prostate-associated, MHC-II-restricted antigen of unknown identity and mediates Treg cell development in the thymus via an Aire-dependent process (Malchow et al., 2013) . To screen for antigenic activity, we used an in vitro culture system to monitor the proliferation of TCR transgenic T cells expressing the MJ23 TCR (MJ23tg T cells). Using this system, we found that splenic dendritic cells (DCs) cultured with protein extracts from the dorsolateral or anterior (but not ventral) lobes of the prostate induced proliferation of MJ23tg T cells ( Figure 1A) , demonstrating that the relevant peptide can be isolated and detected by T-cell-based assays.
We reasoned that the MJ23 peptide antigen would fit three criteria: (1) the protein containing the peptide would be exclusively or preferentially expressed in the prostate, (2) the gene encoding this protein would be a transcriptional target of Aire in medullary thymic epithelial cells (Anderson et al., 2002; Derbinski et al., 2005; Sansom et al., 2014) , and (3) this gene would not be located on the Y chromosome, because MJ23tg Treg cells undergo thymic development in both male and female mice (Malchow et al., 2013) .
Using data from a transcriptional profiling study (Sansom et al., 2014) , we identified 20 candidate genes fitting these criteria (Table S1 ) and expressed the corresponding proteins recombinantly in insect cells. We cultured DCs with individual proteins and assayed for their capacity to induce proliferation of MJ23tg T cells ( Figure 1B and Figures S1A and S1B). One of these candidates, encoded by TRPM8 channel-associated factor 3 (Tcaf3, also known as Eapa2 or Fam115e), induced robust stimulation of MJ23tg T cells in vitro ( Figure 1B ). Stimulation was abolished by anti-MHC-II blocking antibody, and Tcaf3 did not induce stimulation of transgenic T cells of an irrelevant specificity (Barnden et al., 1998) (Figure 1B ). Immunization with recombinant Tcaf3, but not with another Aire-dependent prostatic protein (transglutaminase 4 [Tgm4]; Table S1 ), induced robust proliferation of MJ23tg T cells in vivo ( Figure 1C) , demonstrating that the Tcaf3-derived peptide can be efficiently processed and presented in vivo. To identify the peptide epitope recognized by MJ23tg T cells, we used in silico approaches (Vita et al., 2015; Zhu et al., 2003) to generate a list of Tcaf3-derived peptides predicted to bind I-A b , the only functional MHC class II protein expressed in these mice. Of these candidate peptides, we identified one peptide, with sequence THSKAPWGELATD and spanning residues 646-658 of Tcaf3, that robustly stimulated MJ23tg T cells in vitro ( Figure 1D ). Subsequent analysis of peptide truncations revealed the minimal core epitope to be the nonamer SKAPWGELA (residues 648-656) ( Figure 1E) ) littermates of the indicated ages. Data represent multiple independent experiments: n = 4 (A), 2 (F), 3 (B, C, E, and G), and 5 (D). See also Figure S1 . (Fujimoto et al., 2006) , consistent with our data on MJ23tg T cell stimulation ( Figure 1A ). Of note, previous studies have demonstrated that Tcaf3 is targeted by autoantibodies in multiple experimental mouse models characterized by prostatic autoimmunity, including neonatal thymectomy (Setiady et al., 2006) , castration (Meng et al., 2011) , and Aire deficiency (Setiady et al., 2006) . Concordant with these published results, we recurrently detected serum antibodies reactive to recombinant Tcaf3 in Aire-deficient males greater than 10 weeks of age, but not in age-matched, Aire-sufficient control mice ( Figure 1G ). Thus, cumulative evidence demonstrates that Tcaf3 is highly susceptible to recognition by autoantibodies in settings of immune dysregulation.
Identifying Endogenous Tcaf3-Specific T Cells by Using pMHC-II Tetramers
Having identified the peptide ligand recognized by the MJ23 Treg cell clone, we aimed to directly identify, enumerate, and characterize endogenous, polyclonal Tcaf3 646-658 -specific T cells by using pMHC-II tetramers. We generated fluorescently labeled I-A b tetramers bearing a variant of the antigenic Tcaf3 646-658 peptide (hereafter referred to as Tcaf3/I-A b tetramers) (Malhotra et al., 2016) . We used a peptide variant in which serine 648, predicted to lie at an MHC-binding anchor position, was changed to tyrosine, a preferred anchor residue at this position (Liu et al., 2002; Zhu et al., 2003) . This alteration enabled production of stable Tcaf3/I-A b tetramers and slightly enhanced the potency of peptide stimulation of MJ23tg T cells in vitro ( Figure 2A ). Tcaf3/I-A b tetramers bearing this variant peptide stained MJ23tg T cells but did not bind nonspecifically to polyclonal cells ( Figure 2B ), demonstrating specificity of binding.
Using this reagent, we first sought to characterize endogenous, polyclonal Tcaf3 646-658 -specific T cells in healthy mice. To do this, we employed an established approach in which rare antigen-specific T cells were expanded in vivo by immunization with peptide plus complete Freund's adjuvant (CFA) and expanded T cells were analyzed 14 days later after magnetic enrichment of Tcaf3/I-A b -tetramer + T cells from the pooled spleen and lymph nodes (Legoux and Moon, 2012; Malhotra et al., 2016; Moon et al., 2007) . We co-stained T cells with both phycoerythrin (PE)-and allophycocyanin (APC)-labeled tetramers simultaneously to reduce false-positive staining (Stetson et al., 2002; Tubo et al., 2013) . As a control, we immunized mice with the I-A b -restricted foreign peptide 2W1S and used 2W1S/I-A b tetramers to characterize antigen-specific T cells (Moon et al., 2007 (Greenberg et al., 1995; Malchow et al., 2013) . Given that the MJ23 TCR represents a single Tcaf3 646-658 -specific TCR clone, it was not previously possible to quantify the total contribution of polyclonal Tcaf3 646-658 -specific Treg cells to the T cell infiltrate of TRAMP prostate tumor lesions. To address this, we performed tetramer analysis of T cells isolated from 6-to 7-month-old TRAMP males bearing late-stage prostate tumors. Tcaf3/I-A b tetramer + T cells were readily detected in all TRAMP prostate tumors examined, composing an average of $2.1% (±0.63 SEM) of all tumor-infiltrating Treg cells (Figures 3A and 3B) . Consistent with the above results and previous studies of the MJ23 clone (Malchow et al., 2016; Malchow et al., 2013) , prostate-tumor-infiltrating Tcaf3/I-A b tetramer + T cells were strongly skewed to the Foxp3 + Treg cell subset ( Figures  3A and 3B) .
In previous studies, we demonstrated that Aire is critical for the thymic development of monoclonal MJ23 Treg cells (Malchow et al., 2013) and showed that in the absence of Aire, MJ23 T cells emerge in the Foxp3 À Tconv cell subset and recurrently infiltrate autoimmune prostatic lesions of Aire À/À males (Malchow et al., 2016) . We therefore predicted that polyclonal ) or 20 nM (TRAMP) of each tetramer. Significance testing was performed with the nonparametric Mann-Whitney test (**p < 0.001; ***p < 0.0001; n.s., not significant). Figures 2D and 2E) (Malchow et al., 2016) . The most abundant of these Aire-dependent, prostate-associated clones, named SP33 in the current study, expressed a TCRa chain of complementarity determining region 3 a (CDR3a) sequence TRAV9D-ALSMSVNYQLI in combination with the same fixed transgenic TCRb chain as the MJ23 clone (Malchow et al., 2016; STAR Methods) . Of note, compared with the MJ23 TCRa chain (TRAV14-LYYNQGKLI), the SP33 TCRa chain utilizes a different V region segment and exhibits little sequence similarity within CDR3a. To study the peptide specificity of the SP33 TCR, we generated SP33 TCR ''retrogenic'' (SP33rg) mice (McDonald et al., 2015; Turner et al., 2010) in which bone marrow progenitors retrovirally transduced with an SP33 TCR expression construct were engrafted into host mice. Using resulting SP33rg T cells as a probe for pMHC-II ligand, we found that DCs cultured with protein extracts from the dorsolateral or anterior prostatic lobes stimulated CD4 + SP33rg T cells in vitro (Figure 4A) , mirroring the results of MJ23 T cell stimulation assays ( Figure 1A) . Screening of the candidate prostate-specific proteins described above revealed that Tcaf3, the same protein containing the peptide ligand recognized by MJ23 T cells, robustly stimulated SP33rg T cells in vitro ( Figure 4B ) and in vivo ( Figure 4C) .
Foxp3 (
Given that the TCRa chains of the MJ23 and SP33 TCRs exhibit little sequence similarity, we predicted that the MJ23 and SP33 TCRs might recognize distinct Tcaf3-derived peptides. Consistent with this, screening of the panel of synthetic Tcaf3 peptides demonstrated that SP33rg T cells were robustly stimulated by a peptide of sequence CPGAPIAVHSSLASLVNILG (Tcaf3 88-107 ) ( Figures 4D and 4E ) and were not stimulated by the MJ23 agonist peptide THSKAPWGELATD (Tcaf3 646-658 ) ( Figure 4D ). Together, our data demonstrate that two recurrent Treg cell clones, the first identified in mouse prostate tumors (MJ23) and the second identified in prostatic autoimmune lesions in Aire À/À mice (SP33), recognize two distinct peptides derived from a single prostatespecific protein, Tcaf3.
DISCUSSION
Because of the technical challenges associated with identifying MHC-II-restricted self-peptides, the natural antigens recognized by recurrent thymus-derived Treg cell populations have thus far remained elusive. In this study, we identified endogenous Treg cell ligands in mice, demonstrating that two recurrent Treg cell clones, the first identified in mouse prostate tumors (MJ23) and the second associated with prostatic autoimmune lesions (SP33), recognize distinct non-overlapping peptides derived from a single prostate-specific protein, Tcaf3. By focusing our efforts on Aire-dependent Treg cell specificities reactive to tissue-specific antigens, we generated a tractable list of candidates by using available transcriptional profiling data, which enabled screening for antigenic activity by standard immunological assays. As discussed below, the findings and experimental approach described here have implications for basic Treg cell biology and for the discovery of additional Treg cell ligands in mice and humans. Previous reports have demonstrated that a minor fraction of Foxp3 + Treg cells can be identified within antigen-specific T cell populations reactive to both self-and foreign pMHC-II (Malhotra et al., 2016; Moon et al., 2011; Su et al., 2016) . However, these populations do not reflect naturally occurring antigen specificities that drive the robust selection of Treg cells in the thymus. For example, immunization with self-peptide plus adjuvant is commonly used to induce tissue-specific autoimmunity in animal models such as experimental autoimmune uveitis and experimental autoimmune encephalomyelitis Rangachari and Kuchroo, 2013) . In such models, immunization induces the emergence of both Tconv and Treg cells specific to the antigenic self-peptide (Kieback et al., 2016; Korn et al., 2007; Silver et al., 2015) . However, in these settings, antigen-specific Treg cells are outnumbered by pathogenic Tconv cells of the same specificity and fail to prevent autoimmune pathology (Kieback et al., 2016; Korn et al., 2007; Silver et al., 2015) . Furthermore, it is unclear whether Foxp3 + Treg cells specific to these self-peptides are present in the endogenous repertoire in the absence of peptide immunization. These findings suggest that these self-peptides do not efficiently direct T cells into the Treg cell lineage. In contrast to these studies, our previous work using TCR repertoire profiling demonstrated that at steady state, in the absence of peptide immunization, the Tcaf3-specific T cell clones MJ23 and SP33 are strongly skewed to the Foxp3 + Treg cell lineage (Malchow et al., 2016; Malchow et al., 2013) . The importance of directing these clonotypes into the Treg cell lineage is revealed when this process is dysregulated in Aire À/À mice, in which the MJ23 and SP33 clones are misdirected into the Tconv subset and infiltrate autoimmune lesions of the prostate (Malchow et al., 2013) . Our current data using pMHC-II tetramers corroborate and extend these findings, demonstrating that endogenous polyclonal Because little is known about the identity of the self-antigens that direct Treg cell development in the thymus, it has not been possible to determine whether the differentiation of a given Treg cell clone relies on the specific recognition of a single agonist ligand or can be conferred by TCR cross-reactivity to an array of self-ligands. By generating Tcaf3 tm1 mice harboring a targeted deletion of the Tcaf3 646-658 13-mer peptide, we demonstrated that MJ23 Treg cell development was abolished in Tcaf3 tm1/tm1 mice. Thus, the thymic development of this tissue-specific Treg cell clone requires thymic expression of a single self-peptide and cannot be mediated by reactivity to other self-ligands presented in the thymus. The data presented here, combined with evidence from previous studies (Malchow et al., 2016; Malchow et al., 2013 ), support a model in which the Aire-dependent presentation of Tcaf3-derived peptides directs Tcaf3-specific thymocytes into the Treg cell lineage. In the absence of Aire, Tcaf3-specific T cells, including the MJ23 and SP33 clonotypes, become skewed to the Tconv subset and infiltrate the prostate. Informally, we refer to these cells as T-rogue cells-Treg-cell-biased clonotypes that ''go rogue'' in a setting of Aire deficiency (Malchow et al., 2016) . Of note, Aire À/À mice also develop autoantibodies against Tcaf3, most likely aided by the provision of T cell help by T-rogue cells. Consistent with this notion, a recent study demonstrated that Aire-deficient human subjects harbor highly mutated, high-affinity autoantibodies (Meyer et al., 2016) , indicative of T-helper-cell-dependent affinity maturation. Thus, our data reveal a link between the pMHC-II antigens recognized by Aire-dependent, tissue-specific Treg cells and the protein antigens recognized by autoantibodies in settings of Aire deficiency. On the basis of this conceptual link, we hypothesize that the specificities of autoantibodies that arise in human subjects with loss-of-function AIRE mutations (Landegren et al., 2016; Meyer et al., 2016) could reveal the specificities of recurrent Aire-dependent Treg cell populations in humans. One such candidate is the prostatic protein Tgm4, which is recurrently targeted by autoantibodies in AIRE-deficient men and Aire À/À male mice (Landegren et al., 2015; Meyer et al., 2016; Setiady et al., 2006) . Broadly speaking, we suggest that this approach could serve as a general strategy for identifying the constellation of tissue-specific selfpeptides that are targeted by recurrent Treg cell populations relevant to human autoimmune diseases and cancer. The concept of immunodominance, in which the immune response is focused on a limited set of antigenic determinants, has been demonstrated extensively for effector T cell responses directed at foreign antigens (Sercarz et al., 1993; Yewdell, 2006) . Our finding that two recurrent prostate-associated Treg cell clones recognize distinct peptides derived from a single self-protein raises the possibility that the concept of immunodominance might extend to Treg cell antigen recognition at regional sites and that Treg cell populations at a given site might be largely focused on those autoantigens that are most susceptible to autoimmune attack. Early studies of TCR repertoire complexity in the secondary lymphoid organs have demonstrated that the diversity of the bulk Treg cell repertoire in naive mice is comparable to that of the Tconv cell repertoire (Hsieh et al., 2004; Pacholczyk et al., 2006; Wong et al., 2007) , suggesting that the peripheral Treg cell repertoire is not focused on a limited array of antigens. However, a subsequent survey revealed that Treg-cell-expressed TCRs are asymmetrically distributed in lymph nodes throughout the body, suggestive of antigen-driven enrichment of distinct Treg cell clones in regional lymph nodes (Lathrop et al., 2008) . More recently, analyses of the Treg cell repertoire in mouse prostate tumors (Malchow et al., 2013) and non-lymphoid organs such as muscle (Burzyn et al., 2013) and visceral adipose tissue (Feuerer et al., 2009; Kolodin et al., 2015) have revealed the enrichment of oligoclonal Treg cell populations at these sites, some of which were recurrent. Integrating this evidence with our current findings, we envision a model of ''regional Treg cell immunodominance,'' in which select Treg cell specificities are drawn from the diverse peripheral Treg cell pool and enriched and/or expanded in response to inflammatory reactions at different non-lymphoid sites.
In addition to Tcaf3, other studies in the literature have described autoimmune responses converging on a single tissue-specific autoantigen. For example, it has been shown that Aire deficiency in mice on the B6 background leads to the development of effector T cell and autoantibody responses directed at unique structures of the eye (Anderson et al., 2002; Jiang et al., 2005) . Intriguingly, the development of uvea-specific autoimmunity in Aire À/À mice is dependent on the peripheral expression of a single target antigen, retinol binding protein 3 interstitial (Rbp3, also known as interphotoreceptor retinoid binding protein [IRBP] ; DeVoss et al., 2006) . Moreover, in an Aire +/+ setting, deficiency of Rbp3 specifically in the thymus is sufficient to induce uveitis (DeVoss et al., 2006) . Although it remains unclear whether T-rogue cells specific to Rbp3 are implicated in this system, the results support the idea that provocation of autoimmune responses to the eye in mice could be uniquely focused on a limited number of autoantigens such as Rbp3. Finally, the identification of endogenous self-peptides recognized by Aire-dependent tTreg cell populations will enable the interrogation of fundamental questions in Treg cell biology, which have thus far been experimentally intractable. First, the role of cognate antigen in driving the thymic development and peripheral homeostasis of Tcaf3-specific Treg cells and the role of TCR-pMHC affinity in coordinating these processes can be addressed in future studies. Second, the establishment of Tcaf3/I-A b tetramers will permit the enumeration and phenotypic analysis of endogenous Tcaf3-specific T cells at different stages of ontogeny and in various settings of health and disease. Third, our findings will enable studies to determine the structural and biochemical basis of antigen recognition by the MJ23 and SP33 TCRs to determine whether tTreg cell TCRs recognize self-antigen with unique binding characteristics. Lastly, the Tcaf3 system could provide a model for the development of additional approaches for the treatment of autoimmune or inflammatory disorders on the basis of the selective in vivo expansion of organ-specific Treg cells and the recruitment of such cells to inflamed sites.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
The following mice were purchased from the Jackson Laboratory, and bred and maintained at the University of Chicago: C57BL/6J ( 
CD45
.1/.1 and ''TCRbtg'' mice expressing a fixed TCRb chain of sequence TRBV26-ASSLGSSYEQY were generated as described previously (Malchow et al., 2013) . All mice were generated on a pure B6 background or were fully backcrossed to the B6 background. All mice were bred and maintained under specific pathogen free conditions in accordance with the animal care and use regulations of the University of Chicago. Mice were housed in sterile and ventilated micro-isolation cages, up to five mice per cage, and fed irradiated standard pellet chow and reverse osmosis water ad libitum in a 12 hr light/dark cycle, with room temperature at 22 C ± 1 C. All cages contained sterile quarter-inch corncob bedding and a nestlet for environmental enrichment. Mice for experiments were age-matched, were littermates when possible, and were assigned to experimental groups based on genotype.
Generation of Tcaf3
tm1 Mice Tcaf3 tm1 mice harboring genetic deletion of the region encoding the Tcaf3 646-658 peptide were generated on the B6 background by Cyagen Biosciences using CRISPR/Cas9-based targeting and homology-directed repair. In founder lines, the lack of mutations in off-target genes was verified by PCR amplification and sequencing of select candidate genes. Intercross of heterozygous Tcaf3 +/tm1 mice yielded healthy offspring at Mendelian ratios. The targeted region of the Tcaf3 gene is presented below, with the deleted segment shown in bold, and the genotyping primer sites underlined: CCACTTAACTTCATCCCAGACATCCATCTCCTGGCTCTATGGGGGCCTTCTCTACATCATGGTCCCCAACAAATATAATCAGGAT AATGTGTCTGTCACCATCCGTGGGGCTGTATCTGCTCCATACTTCAGGCTGGGTAAGACGACCCAGGAGGAATGGAAGAATCTTA TCACACACAGCAAAGCTCCGTGGGGAGAACTAGCCACAGACAATATCATCCTGACAATTCCAACGGTAAACCTCAAGGAGCTTC AGGACCCCTATCCACTGCTCCAACTCTG.
Cell Lines
High Five insect cells (Trichoplusia ni, female, ovarian) were used for production of recombinant prostatic proteins ( Figures 1B,  1C , 1G, 4B, 4C, and S1A); cells were grown in Insect-XPRESS Protein-Free Insect Cell Medium supplemented with additional L-glutamine (2 mM) and gentamicin sulfate (50 mg/mL), in suspension culture shaking at 120 rpm and 27 C. Drosophila S2 cells were used for recombinant production of I-A b ; cells were transfected according to the Drosophila Expression System manual (Thermo Fisher) in Schneider's Drosophila medium supplemented with 10% FBS, 1X Pen/Strep (100 U/mL penicillin, 0.1 mg/mL streptomycin), and 20 mg/mL gentamicin, and maintained in stationary cultures at 27 C. S2 transfectants were selected with 25 mg/mL Blasticidin, and stable lines were expanded for expression in Express Five SFM supplemented with 25 mg/mL Blasticidin, 1X Pen/Strep (100 U/mL penicillin, 0.1 mg/mL streptomycin), and 20 mg/mL gentamicin, in suspension culture shaking at 120 rpm and 27 C.
Bacteria E. coli DH5a was cultured at 37 C shaking at 250 rpm. E. coli W3110 strain 33D3 was used for production of recombinant prostatic proteins ( Figure S1B ); 33D3 bacteria were cultured at 37 C shaking at 250 rpm and then switched to 30 C for protein expression.
METHOD DETAILS Preparation of Prostatic Extracts
The procedure for the preparation of prostatic secretory extracts was adapted from Fujimoto et al. (2006) . Prostates of tumorbearing TRAMP male mice of 6 months of age, or age-matched Tcaf3 +/+ or Tcaf3 tm1/tm1 males of 6-8 weeks of age, were dissected to separate the anterior, ventral, and dorsolateral lobes. The dissected lobes were incubated separately in 1-2 mL PBS for 5 min at room temperature to extract secreted proteins, and then spun for 5 min at 10,000 3 g at 4 C. The supernatant was transferred to a fresh tube and spun again for 5 min at 13,200 3 g at 4 C. The supernatant from this second spin was retained and total protein content was quantified by BCA protein assay (Pierce). These secretory extracts were flash frozen in liquid nitrogen and store at À80 C until use.
Production of Recombinant Prostatic Proteins
Tcaf3, Tgm4, and Svs2 proteins used in Figures 1C, 4C , and S1A were produced recombinantly in High Five insect cells (Thermo Fisher) with an N-terminal gp67 secretion signal and 8xHis tag. Tagged proteins were purified from culture supernatant by nickel affinity chromatography, and their His tags were removed by cleavage with 3C protease. Protease and uncleaved proteins were removed by a second pass over nickel resin. Pate4, Sbpl, Wfdc3, Msmb, and Svs4 proteins used in Figure S1B were produced recombinantly in 33D3 E. coli by periplasmic secretion as previously described (Maynard et al., 2005) . Briefly, proteins were expressed with an N-terminal PELB secretion signal and C-terminal 6xHis tag. Periplasmic proteins were isolated by osmotic shock in a solution of sucrose, EDTA and lysozyme. Following neutralization with MgCl 2 , recombinant proteins were purified by nickel affinity chromatography. All recombinant proteins were exchanged into PBS using a Zeba desalting spin column (Thermo Fisher) and sterilized by 0.22 mm filtration. Tcaf3 (GenBank: NM_203396.1) The Tcaf3 protein sequence (underlined) was fused at its N terminus to the gp67 secretion signal sequence, an 8xHis tag, a 3C protease cleavage site, and intervening linker sequences. A slash (''/'') indicates where N-terminal tags were cleaved from the mature protein.
MLLVNQSHQGFNKEHTSKMVSAIVLYVLLAAAAHSAFAADLHHHHHHHHGSGGLEVLFQ/GPERGSHMAMATTPDAAFETLMNGVT SWDLPKEPIPSELLLTGESAFPVMVNDKGQVLIAASSYGQGRLVVVSHESYLLHDGLVPFLLNVVKWLCPCPGAPIAVHSSLASLVNILG DSGINALVQPEPGEALGVYCIDAYNDALTEKLIQFLKNGGGLLIGGQALNWAAHHGHDKVLSIFPGNQVTSVAGVYFTDISANRDWFKVS KEIPNLRLYVQCEDELEDDQQQLLKGMSEIYIEAGVIPSQLLVHGQRAFPLGVDNSLNCFLAAARYGRGRVVLGGNESLILNQTMLPFVL NALHWLMGNQTGRIGLASDMKVLKSMLPNSSFQWSESELLTSDLSVFCCCSLANIDSEEVEEFVAEGGGLLIGAEAWSWGRRNPYSS CMTQYPDNIVLKRFGLGITSHVAQRGSFPFPNPEGTNYHFRRALSQFESVIYSRGSSLHESWLNKLSQDCFYMFQMTHQRISIYDSVKK HALKMIQSKDFPSVTEQYPIARGSSQAFLLSLAYELFKSGVDRSQLLPPPALLPPTESPITIKISTDNDNSWVSTGLYLPEGQVAQVLLPSE ATHAKLKVLIGCHRDNISQARTYFRPPVMTYVYHLTSSQTSISWLYGGLLYIMVPNKYNQDNVSVTIRGAVSAPYFRLGKTTQEEWKNLIT HSKAPWGELATDNIILTIPTVNLKELQDPYPLLQLWDKMVRAVAKLAARPFPFQRAERVVLDKQISFGFLHSGYPIMGLISIVEGIISEFKIR SHGIWGVIHELGHNHQKSGWTFPPHTTEALCNLWTIYVHETVLNIPREQAHPSLNPELRRQRIKYHLNKGAPLSNWIMWTALETYLQLQ EGFGWEPFIQVFADYRTLSGLPQNNEDKMNLWVKKFSEAVHKNLAPFFEAWGWPVKYAVAKSLASLPEWQENPMKRYTAEGTEGRE Svs2 (GenBank: NM_017390.4) The Svs2 protein sequence (underlined) was fused at its N terminus to the gp67 secretion signal sequence, an 8xHis tag, a 3C protease cleavage site, and intervening linker sequences. A slash (''/'') indicates where N-terminal tags were cleaved from the mature protein.
MLLVNQSHQGFNKEHTSKMVSAIVLYVLLAAAAHSAFAADLHHHHHHHHGSGGLEVLFQ/GPEGGSQYGATKGHFQSSSSEGFML GQKGRLSFGIKGGSDEAAEESLFMQSQRRVYGQGGGDMTQTRVSQEHTSVKGAALCRNGQVSQLKSQESQIKSYGQVKSSGQLKSG GSAFGQVKSSVSQIKSYGQLKSGGQLKSGGPAFGQVKSQESQIKSYGQLKSSGQLKSGGSAFGQVKSSVSQIKSYGQLKSGGSQVKS YGQTKSYGEEGQLNSFSQLKSQGAQLKSYGQQKSQQQSSFSQVKSQSSQLKSYGQQKSLKGFSQQTQHKGFAMDEGMSQVRKQF SDDDLSVQQKSTQQMKTEEDLSQFGQQRQYGQERSQSYKGYLEQYRKKVQEQQRKNFNPGNYFTKGGADLYQAQLKG Tgm4 (GenBank: NM_177911.4) The Tgm4 protein sequence (underlined) was fused at its N terminus to the gp67 secretion signal sequence, an 8xHis tag, a 3C protease cleavage site, and intervening linker sequences. A slash (''/'') indicates where N-terminal tags were cleaved from the mature protein.
MLLVNQSHQGFNKEHTSKMVSAIVLYVLLAAAAHSAFAADLHHHHHHHHGSGGLEVLFQ/GPERGSHMAANVLIIYAVNVERKLNAA AHHTSEYQTKKLVLRRGQIFTLKVILNRPLQPQDELKVTFTSGQRDPPYMVELDPVTSYRSKGWQVKIAKQSGVEVILNVISAADAVVGR YKMRVNEYKAGVFYLLFNPWCSDDSVFMASEEERAEYILNDTGYMYMGFAKQIKEKPWTFGQFEKHILSCCFNLLFQLENNEMQNPVL VSRAICTMMCAANGGVLMGNWTGDYADGTAPYVWTSSVPILQQHYVTRMPVRYGQCWVFSGILTTALRAVGIPARSVTNFESAHDTEK NLTVDIYLDESGKTIPHLTKDSVWNFHVWTDAWMKRQDLPHGYDGWQVLDSTPQEISDGGFRTGPSPLTAIRQGLIQMKYDTTFVFTEV NGDKFIWLVKQNQEREKNILIAVETASIGKKISTKMVGENRREDITLQYKFPEGSPEERKVMAKASGKPSDDKLNSRTLNNSLQISVLQN SLELGAPIYLTITLKRKTATPQNVNISCSLNLQTYTGNKKTNLGVIQKTVQIHGQESRVFLTMDASYYIYKLGMVDDEMVIGGFIIAEIVDSG ERVATDTTLCFLYSAFSVEMPSTGKVKQPLVITSKFTNTLPIPLTNIKFSVESLGLANMKSWEQETVPPGKTITFQMECTPVKAGPQKFIV KFISRQVKEVHAEKVVLISK Pate4 (GenBank: NM_020264.4) The Pate4 protein sequence (underlined) was fused at its N terminus to the PELB secretion signal sequence and a short linker, and at its C terminus to a short linker and a 6xHis tag. A slash (''/'') indicates the predicted boundary between the secretion signal and the mature protein.
MKSLLPTAAAGLLLLAAQ/PAMALICNSCEKSRDSRCTMSQSRCVAKPGESCSTVSHFVGTKHVYSKQMCSPQCKEKQLNTGKKLI YIMCCEKNLCNSFAASGADHHHHHH. Sbpl (GenBank: NM_001077421.1) The Sbpl protein sequence (underlined) was fused at its N terminus to the PELB secretion signal sequence and a short linker, and at its C terminus to a short linker and a 6xHis tag. A slash (''/'') indicates the predicted boundary between the secretion signal and the mature protein.
MKSLLPTAAAGLLLLAAQ/PAMAQNVLGNAAGKYFYVQGEDQGQLKGMRIFLSVFKFIKGFQLQFGNNWTDVYGSRSDNFIDFLLED GEHVIKVEGSAVICLTSLTFTTNKGRVATFGVRRGRYFSDTGGSDKHLVTVNGMHAPGLCVTGMGFKWEDNAKDLGSPEPVKEPKDS SDSSNKKEDEGRGKDDDDNDEDEDDNDEDENNYGNDDDDDDNDDQKDESAASGADHHHHHH. Wfdc3 (GenBank: NM_027961.1) The Wfdc3 protein sequence (underlined) was fused at its N terminus to the PELB secretion signal sequence and a short linker, and at its C terminus to a short linker and a 6xHis tag. A slash (''/'') indicates the predicted boundary between the secretion signal and the mature protein.
MKSLLPTAAAGLLLLAAQ/PAMAGEHALRGECPADPLPCQELCTGDESCPQGHKCCSTGCGHACRGDIEGGRDGQCPRILVGLCIV QCMMDENCQSGERCCKSGCGRFCIPGLQPLQQLKDSNLTDGFNSKLEAQAPAASGADHHHHHH. Msmb (GenBank: NM_020597.3) The Msmb protein sequence (underlined) was fused at its N terminus to the PELB secretion signal sequence and a short linker, and at its C terminus to a short linker and a 6xHis tag. A slash (''/'') indicates the predicted boundary between the secretion signal and the mature protein.
MKSLLPTAAAGLLLLAAQ/PAMAVCSIENREIFPNQMSDDCMDADGNKHFLNTPWKKNCTWCSCDKTSITCCTNATRPLSYDKDNC DVQFHPENCTYSVVDRKNPGKTCRVDSWTMAASGADHHHHHH. Svs4 (GenBank: NM_009300.3) The Svs4 protein sequence (underlined) was fused at its N terminus to the PELB secretion signal sequence and a short linker, and at its C terminus to a short linker and a 6xHis tag. A slash (''/'') indicates the predicted boundary between the secretion signal and the mature protein.
MKSLLPTAAAGLLLLAAQ/PAMAKKTKEKFLQSEETVRESFSMGSRGHMSRSSEPEVFVRPQDSIGDEASEEMSSSSSSRRRSKIISS SSDGSNMEGESSYSKRKKSRFSQDALEAASGADHHHHHH. CTV-labeled T cells were co-cultured with 5 3 10 4 CD11c + splenocytes, 100 U/mL recombinant mouse interleukin-2 (IL-2), and prostatic extract, proteins, or peptides as indicated. Additionally, anti-MHC-II antibody clone M5 (eBioscience) or IgG2b, k isotype control antibody (BD PharMingen) was added to indicated cultures at a final concentration of 10 mg/mL. Cell cultures were set up in 384-well ultra-low attachment, round-bottom plates (Corning). Dilution of CTV was assessed by flow cytometry on day 3 or day 5 as indicated. Vita et al., 2015) and an in-house peptide scoring script based on the amino acid position probabilities reported by Zhu et al. (2003) . Top-scoring peptides from either method were synthesized and assayed as described below. Of note, the validated antigenic peptide (Tcaf3 646-658 ) was predicted by Zhu et al., but not by the IEDB.
In Vitro T Cell Stimulation
In Vivo T Cell Stimulation
Peptides
The top 36 candidate peptides were synthesized in Sigma's PepScreen format, and the crude, unpurified peptides were screened for in vitro stimulation of MJ23tg T cells as described above. Truncation mutants were also synthesized in the PepScreen format and assayed as crude peptides. All other peptide experiments were performed with peptides synthesized and purified to >98% purity (GenScript).
Tcaf3 Western Blot
Serum was isolated from Aire-sufficient (Aire +/+ or Aire +/À ) or Aire-deficient (Aire À/À ) males at varying ages. 3 mg Tcaf3 protein was loaded onto a 1-well 4%-20% SDS-PAGE gel (Bio-Rad; $38 ng protein per mm lane width) and transferred to nitrocellulose membrane. The membrane was blocked for 1 hr at room temperature with 3% w/v BSA in TBSt (20 mM Tris pH 7.5, 150 mM NaCl, 0.1% v/v Tween 20), and then assembled into a Mini-PROTEAN II Multiscreen Apparatus (Bio-Rad). Sera were diluted 1:400 in TBSt + 3% w/v BSA + 0.1% w/v sodium azide, loaded into separate channels of the Multiscreen Apparatus, and incubated overnight at 4 C. Channels were washed with TBSt in the Apparatus, then the membrane was removed from the Apparatus, washed again with TBSt, and blotted for 1 hr at room temperature with bovine anti-mouse-IgG HRP conjugate (Santa Cruz Biotechnology, sc-2371) diluted 1:10,000 in TBSt + 5% w/v nonfat dried milk. The membrane was washed with TBSt, incubated with SuperSignal West Pico chemiluminescent substrate (Thermo Fisher) and imaged on a ChemiDoc imager (Bio-Rad).
I-A b Tetramer Production
Tcaf3/I-A b tetramers bearing the Tcaf3 646-658 (648Y) peptide (THYKAPWGELATD) and 2W1S/I-A b tetramers bearing the 2W1S peptide (EAWGALANWAVDSA) were produced using methods similar to those described previously (Moon et al., 2007) . I-A b was expressed in Drosophila S2 cells, using separate plasmids to encode the alpha and beta chains, as described previously (Moon et al., 2007) . Constructs were co-transfected into Drosophila S2 cells together with a plasmid encoding the BirA biotin ligase. Protein expression was induced with the addition of 0.8 mM CuSO 4 , in the presence of 2 mg/mL biotin (Sigma-Aldrich). Biotinylated I-A b protein was purified from culture supernatant by nickel affinity chromatography with His Bind Ni-IDA resin (EMD Millipore) and by avidin affinity chromatography with Pierce Monomeric Avidin UltraLink Resin (Thermo Fisher). Tetramers were formed by mixing biotinylated I-A
